FDA Drug information
Oxybutynin Chloride Extended Release
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 10 mg/1 A-S Medication Solutions
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 10 mg/1 American Health Packaging
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 10 mg/1 Aphena Pharma Solutions - Tennessee, LLC
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 10 mg/1 AvKARE
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 10 mg/1 AvPAK
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 10 mg/1 Lannett Company, Inc.
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 10 mg/1 PD-Rx Pharmaceuticals, Inc.
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 10 mg/1 Rising Pharma Holdings, Inc.
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 15 mg/1 Aphena Pharma Solutions - Tennessee, LLC
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 15 mg/1 AvKARE
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 15 mg/1 AvPAK
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 15 mg/1 Lannett Company, Inc.
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 15 mg/1 Rising Pharma Holdings, Inc.
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 5 mg/1 A-S Medication Solutions
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 5 mg/1 American Health Packaging
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 5 mg/1 Aphena Pharma Solutions - Tennessee, LLC
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 5 mg/1 AvKARE
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 5 mg/1 AvPAK
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 5 mg/1 Drug Ocean LLC
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 5 mg/1 Lannett Company, Inc.
- Oxybutynin Chloride Extended Release OXYBUTYNIN CHLORIDE 5 mg/1 Rising Pharma Holdings, Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.